← Leaderboards
Brandon Keith Wilder
Oregon Health & Science University
$4,335,505
Attributed
$8,083,784
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2014–25$2.5M$1.9M$1.3M$625K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,083,784 · 5
By mechanism
U01$4,114,200 · 1
R01$2,934,908 · 1
R43$447,450 · 1
R21$423,500 · 1
F32$163,726 · 1
Top collaborators
- Caroline Junqueira4 shared
- Sean C Murphy4 shared
- Marion Avril2 shared
Most similar at Oregon Health & Science University
Same institution · by research overlap
- Jonah B. Sacha$34,199,132
- Caroline Junqueira$1,467,454
- Benjamin J Burwitz$8,362,920
- Paul Kievit$12,790,994
- Kristin Alicia Diez Sauter$509,244
Others in their field
Top investigators on “Vaccines”
- Lawrence Corey · Fred Hutchinson Cancer Center$829,044,908
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$556,540,832
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$515,215,260
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
- Dennis R. Burton · Scripps Research Institute$316,106,418
Research focus
VaccinesSporozoitesMalaria VaccinesMalariaPlasmodiumLiverBloodInfectionParasitesErythrocytesImmunityImmunizationComplexVaccine CandidateT-LymphocyteImmune SystemCircumsporozoite ProteinResponseAntigensAnimal ModelVaccine DevelopmentBaseImmunogenicityVaccination
Grant awards (15)
Integrating human and non-human primate data to understand the acquisition of pre-erythrocytic immunity in the face of previous malaria exposure$1,028,550
U01 · FY2025 · AI · contact PI
A universal malaria T cell vaccine based on HLA-E presentation$706,784
R01 · FY2025 · AI · contact PI
Integrating human and non-human primate data to understand the acquisition of pre-erythrocytic immunity in the face of previous malaria exposure$1,028,550
U01 · FY2024 · AI · contact PI
A universal malaria T cell vaccine based on HLA-E presentation$705,028
R01 · FY2024 · AI · contact PI
Intracellular-acting antibodies for the prevention of malaria liver stage infection$154,000
R21 · FY2024 · AI · contact PI
Integrating human and non-human primate data to understand the acquisition of pre-erythrocytic immunity in the face of previous malaria exposure$1,028,550
U01 · FY2023 · AI · contact PI
A universal malaria T cell vaccine based on HLA-E presentation$771,027
R01 · FY2023 · AI · contact PI
Intracellular-acting antibodies for the prevention of malaria liver stage infection$269,500
R21 · FY2023 · AI · contact PI
Integrating human and non-human primate data to understand the acquisition of pre-erythrocytic immunity in the face of previous malaria exposure$1,028,550
U01 · FY2022 · AI · contact PI
A universal malaria T cell vaccine based on HLA-E presentation$752,069
R01 · FY2022 · AI · contact PI
Biological Equivalence of In Vitro Plasmodium falciparum Culture for Practical Malaria Vaccine Development$217,162
R43 · FY2021 · AI
Biological Equivalence of In Vitro Plasmodium falciparum Culture for Practical Malaria Vaccine Development$230,288
R43 · FY2020 · AI
Mechanisms of antibody protection in pre-erythrocytic and blood stage malaria$58,002
F32 · FY2016 · AI · contact PI
Mechanisms of antibody protection in pre-erythrocytic and blood stage malaria$54,194
F32 · FY2015 · AI · contact PI
Mechanisms of antibody protection in pre-erythrocytic and blood stage malaria$51,530
F32 · FY2014 · AI · contact PI